Compare CSTL & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CSTL | CARE |
|---|---|---|
| Founded | 2007 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.8M | 723.5M |
| IPO Year | 2019 | 2020 |
| Metric | CSTL | CARE |
|---|---|---|
| Price | $34.49 | $30.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $45.50 | $25.00 |
| AVG Volume (30 Days) | ★ 275.5K | 196.2K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.40% |
| EPS Growth | N/A | ★ 30.19 |
| EPS | N/A | ★ 5.18 |
| Revenue | ★ $344,229,000.00 | $20,315,000.00 |
| Revenue This Year | $2.42 | $12.50 |
| Revenue Next Year | $12.69 | $11.82 |
| P/E Ratio | ★ N/A | $5.94 |
| Revenue Growth | 3.66 | ★ 4.65 |
| 52 Week Low | $17.72 | $16.78 |
| 52 Week High | $44.28 | $36.06 |
| Indicator | CSTL | CARE |
|---|---|---|
| Relative Strength Index (RSI) | 58.21 | 40.91 |
| Support Level | $22.88 | $30.41 |
| Resistance Level | $42.03 | $32.29 |
| Average True Range (ATR) | 1.44 | 0.79 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 57.86 | 37.83 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.